Showing results (351-360 of 2,280) with videos related to

Sort By:
Pageof 228
HIV Medicine|December 22, 2015
The effectiveness of electrocautery ablation for the treatment of high-grade anal intraepithelial neoplasia in HIV-infected men who have sex with menJ Burgos, A Curran, S Landolfi, et al.
HIV Medicine|November 28, 2015
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapyA Winston, W Stöhr, A Antinori, et al.
HIV Medicine|September 24, 2015
Estimated cost per HIV infection diagnosed through routine HIV testing offered in acute general medical admission units and general practice settings in EnglandK J Ong, A C Thornton, M Fisher, et al.
HIV Medicine|September 24, 2015
Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet RegimenM Fabbiani, M Zaccarelli, A Latini, et al.
HIV Medicine|October 17, 2015
Presentation of available CTL epitopes that induction of cell-mediated immune response against HIV-1 Koran clade B strain using computational technologyH Park, Y-S Chung, C-H Yoon, et al.
HIV Medicine|August 29, 2015
Live attenuated herpes zoster vaccine for HIV-infected adultsS D Shafran
HIV Medicine|August 14, 2015
Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignanciesK A Salters, A Cescon, W Zhang, et al.
HIV Medicine|August 14, 2015
Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction modelsM Krikke, R C Hoogeveen, A I M Hoepelman, et al.
HIV Medicine|August 19, 2015
Diverticulitis in HIV-infected patients within the United StatesK Cronley, J Wenzke, H Hussan, et al.
HIV Medicine|September 20, 2014
Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patientsF A Gonzalez, E Van den Eynde, S Perez-Hoyos, et al.
Pageof 228